Human papillomavirus (HPV)
- Value cards for human papillomavirus (HPV)
- Payer value deck and frequently asked questions for HPV and HPV-related diseases
- Value pack for a HPV vaccine
- Brief adaptation of a Markov model for a HPV vaccine
- Update of a budget impact model for a HPV vaccine
- Cost-effectiveness analysis of a HPV vaccine for Spain
- HPV vaccination impact model in infectious diseases
- HTA submission for a HPV vaccine
- Manuscript on the German cost-effectiveness analysis of a HPV vaccine
- Manuscript on the Spanish cost-effectiveness analysis of a HPV vaccine
- Systematic literature review on the indirect protection from the HPV vaccination
- Value demonstration and implementation plan for a new HPV test
- Training sales reps on an interactive model for a HPV vaccine
- Analysis and reporting on the budget impact of a HPV vaccine
- One-pager communication tool on cross-protection in HPV
- One-pager on HPV in head and neck cancer
- Revision of one-pagers in HPV vaccines
- Literature review of epidemiology and economic data in HPV
- Update to European one-pager value communication tools for HPV and for a nine-valent HPV vaccine
- e-v@luate platform for HPV vaccines
- Update to a payer value deck in HPV infection
- Evidence package (literature review and value messages) for HPV vaccination
- Adaptation of a Markov model on a HPV vaccine to Belgium
- Development of a rationale for the need for a HPV vaccine
- Development of an evidence compendium for HPV-related head and neck cancers
- One-pager value communication on discounting approaches to HPV vaccination
- Global value dossier modules for HPV vaccination cohorts
- Anthropological study on the impact of HPV-related diseases
- Manuscript on a HPV vaccine acceptance study in middle aged persons
- Value communications for HPV immunisation data systems
- Targeted literature review on a HPV vaccine to support development of a payer value deck and e-v@luate platform
- Value communications development and strategic consultancy for HPV communication strategy
- Value communications support and manuscript on the burden of HPV-related diseases in men globally
- Global value dossier on an alternative dosing schedule in HPV
- Workshop on an alternative dosing schedule in HPV
- HPV dossiers workshops and value message development
- One-pager on HPV-related head and neck cancer
- Development of a PRO strategy in cervical cancer and HPV
- Summary report, top-up literature review, meta-analysis, editorial board and manuscripts on HPV infection and cervical cancer